clinical trial

Results Show Encouraging Survival Data: Nintedanib for Mesothelioma

On June 5, Anna Nowak, MD, PhD, of the University of Western Australia and member of the Meso Foundation’s Science Advisory Board, presented phase II results from LUME-Meso, a mesothelioma clinical trial sponsored by Boehringer Ingelheim, at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
LUME-Meso is a randomized, double-blind, placebo-controlled trial evaluating […]


BREAKING NEWS FROM ASCO: Promising Results Released from Mesothelioma Clinical Trial

This morning, Arnaud Scherpereel, MD, PhD, head of the Pulmonary and Thoracic Oncology Department at the University Hospital of Lille in France, presented the results of the IFCT-1501 MAPS-2 clinical trial at the American Society of Clinical Oncology (ASCO) Annual Meeting. The study was sponsored by the French Cooperative Thoracic Intergroup (IFCT) with drugs and […]


Disparities and Low Participation in Clinical Trials

by Jadmin Mostel, Patient Support and Research Assistant, Mesothelioma Applied Research Foundation
This past March, I attended the National Comprehensive Cancer Network (NCCN) annual conference, and observed a dynamic roundtable discussion about disparities in the medical field. As the conversation was first colored with various factors such as socioeconomic background and language barriers, the conversation took […]


Facing Mesothelioma One Journal Entry at a Time: Part Nine

Tara DeAugustinis has been battling pleural mesothelioma since diagnosed in early 2016 at the age of 45. She and her husband, Rich, have maintained a personal website documenting her journey with the disease via journal entries, and they have decided to share their story with the mesothelioma community. To read part eight of this story, […]


An Interview with Bonnie Anderson on the Importance of Mesothelioma Research

Diagnosed with mesothelioma in 2002, Bonnie Anderson is a 15-year warrior. Throughout this time, she and her husband, John, have been ardent supporters of the Meso Foundation and have established themselves as leading advocates within the mesothelioma community. Through the Mesothelioma Applied Research Foundation’s peer-review research grant program, they personally funded two research studies:

Exploiting Nf2/Merlin […]